SF2165 is the Senate version of the medical cannabis canopy expansion bill, and it stands out for its bipartisan sponsorship. Introduced by Sen. David Dibble (DFL) and co-authored by Senators Zaynab Mohamed (DFL), John Jasinski (R), and Michael Kreun (R), this is one of the few cannabis bills this session with meaningful support from both parties. The bill does the same thing as its House companion HF2426: it increases the square footage of growing space that medical cannabis combination businesses are allowed to use.

The bipartisan support reflects the fact that this is a practical, industry-focused fix rather than a culture war issue. Minnesota's existing medical cannabis businesses have been operating since 2014 and are constrained by canopy limits that were set when the program was much smaller. Patient enrollment has grown, the product range has expanded, and these businesses need more room to grow. The bill simply raises the ceiling on how much space they can devote to cultivating medical cannabis flower and the raw material for medical cannabinoid products.

With both House and Senate versions moving through their respective chambers, this concept has a realistic path forward. The medical cannabis operators who would benefit have been vocal about the need for expanded canopy, arguing that tight limits constrain supply, limit product variety, and drive up costs for patients who are already paying out of pocket for their medicine.